Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

CD8+ lymphocyte responses to antiretroviral therapy of HIV infection

Article Abstract:

Protease inhibitors appear to increase blood levels of CD8 T cells but it is not clear whether this will prevent the progression of HIV infection. Researchers reviewed 7 clinical trials of zidovudine alone or in combination with didanosine or zalcitabine as well as 2 clinical trials of the protease inhibitor ritonavir. Only ritonavir significantly increased CD8 T cell levels. CD8 T cells often rise following HIV infection and drop as the infection progresses to AIDS. This indicates that these immune cells are capable of suppressing the virus.

Author: Cooper, David A., Carr, Andrew, Law, Matthew, Emery, Sean, Kelleher, Anthony
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology
Subject: Health
ISSN: 1077-9450
Year: 1996
Measurement, Protease inhibitors, CD8 lymphocytes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The role of hydroxyurea in enhancing the virologic control achieved through structured treatment interruption in primary HIV infection: Final results from a randomized clinical trial (pulse)

Article Abstract:

Structured treatment interruptions (STIs) are posulated to improve virologic control in primary HIV infection (PHI) by simulating HIV-specific T-lymphocyte immunity. It is concluded that hydroxyurea is found to be beneficial when used in association with STIs in patients during PHI.

Author: Cooper, David A., Kaldor, John M., Carr, Andrew, Zaunders, John J., Law, Matthew, Bloch, Mark T., Ven, Dip, McFarlane, Robert, Smith, Don E., Finlayson, Robert J., Kelleher, Anthony D., Di Quan, Grey, Pat, Irvine, Kathy, Petoumenos, Kathy
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2006
Prevention, Complications and side effects, Dosage and administration, Hydroxyurea, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Buffalo hump seen in HIV-associated lipodystrophy is associated with hyperinsulinemia but not dyslipidemia

Article Abstract:

A study was conducted to identify risk factors for a buffalo hump (BH) in HIV-infected adults in cross-sectional analyses of 2 HIV-infected ambulatory populations. Patients with a BH had a high prevalence of other features of HIVLD, similar to lipodystrophic patients without a BH.

Author: Cooper, David A., Miller, John, Carr, Andrew, Law, Matthew, Mallon, Patrick W.G., Wand, Handan
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
United States, Health aspects, HIV patients, Metabolic diseases, Lipodystrophy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Physiological aspects, HIV infection, HIV infections
Similar abstracts:
  • Abstracts: A practical method to calibrate self-reported adherence to antiretroviral therapy. Repeated measures longitudinal analyses of HIV virologic response as a function of percent adherence, dose timing, genotypic sensitivity and other factors
  • Abstracts: Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: The Swiss HIV cohort study. part 2
  • Abstracts: Mixed patterns of changes in central and peripheral fat following initiation of antiretroviral therapy in a randomized trial. part 2
  • Abstracts: Researchers examine long-term risks of exposure to medical radiation. Researchers use dots to light up tumor cells
  • Abstracts: We need to re-evaluate the priorities and limits of the NHS. We need to change how we care for older people
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.